731 related articles for article (PubMed ID: 33141117)
1. Corticosteroid treatment in severe COVID-19 patients with acute respiratory distress syndrome.
Liu J; Zhang S; Dong X; Li Z; Xu Q; Feng H; Cai J; Huang S; Guo J; Zhang L; Chen Y; Zhu W; Du H; Liu Y; Wang T; Chen L; Wen Z; Annane D; Qu J; Chen D
J Clin Invest; 2020 Dec; 130(12):6417-6428. PubMed ID: 33141117
[TBL] [Abstract][Full Text] [Related]
2. Corticosteroid therapy for coronavirus disease 2019-related acute respiratory distress syndrome: a cohort study with propensity score analysis.
Wu C; Hou D; Du C; Cai Y; Zheng J; Xu J; Chen X; Chen C; Hu X; Zhang Y; Song J; Wang L; Chao YC; Feng Y; Xiong W; Chen D; Zhong M; Hu J; Jiang J; Bai C; Zhou X; Xu J; Song Y; Gong F
Crit Care; 2020 Nov; 24(1):643. PubMed ID: 33172477
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study.
Bartoletti M; Marconi L; Scudeller L; Pancaldi L; Tedeschi S; Giannella M; Rinaldi M; Bussini L; Valentini I; Ferravante AF; Potalivo A; Marchionni E; Fornaro G; Pascale R; Pasquini Z; Puoti M; Merli M; Barchiesi F; Volpato F; Rubin A; Saracino A; Tonetti T; Gaibani P; Ranieri VM; Viale P; Cristini F;
Clin Microbiol Infect; 2021 Jan; 27(1):105-111. PubMed ID: 32971254
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes of intravenous immunoglobulin therapy in COVID-19 related acute respiratory distress syndrome: a retrospective cohort study.
Ali HS; Elshafei MS; Saad MO; Mitwally HA; Al Wraidat M; Aroos A; Shaikh N; Ananthegowda DC; Abdelaty MA; George S; Nashwan AJ; Mohamed AS; Khatib MY
BMC Pulm Med; 2021 Nov; 21(1):354. PubMed ID: 34743710
[TBL] [Abstract][Full Text] [Related]
5. Low-to-moderate dose corticosteroids treatment in hospitalized adults with COVID-19.
Liu Z; Li X; Fan G; Zhou F; Wang Y; Huang L; Yu J; Yang L; Shang L; Xie K; Xu J; Huang Z; Gu X; Li H; Zhang Y; Wang Y; Huang Z; Cao B
Clin Microbiol Infect; 2021 Jan; 27(1):112-117. PubMed ID: 33007478
[TBL] [Abstract][Full Text] [Related]
6. Corticosteroid therapy in critically ill patients with COVID-19: a multicenter, retrospective study.
Li Y; Meng Q; Rao X; Wang B; Zhang X; Dong F; Yu T; Li Z; Feng H; Zhang J; Chen X; Li H; Cheng Y; Hong X; Wang X; Yin Y; Zhang Z; Wang D
Crit Care; 2020 Dec; 24(1):698. PubMed ID: 33339536
[TBL] [Abstract][Full Text] [Related]
7. Latent Class Analysis Reveals COVID-19-related Acute Respiratory Distress Syndrome Subgroups with Differential Responses to Corticosteroids.
Sinha P; Furfaro D; Cummings MJ; Abrams D; Delucchi K; Maddali MV; He J; Thompson A; Murn M; Fountain J; Rosen A; Robbins-Juarez SY; Adan MA; Satish T; Madhavan M; Gupta A; Lyashchenko AK; Agerstrand C; Yip NH; Burkart KM; Beitler JR; Baldwin MR; Calfee CS; Brodie D; O'Donnell MR
Am J Respir Crit Care Med; 2021 Dec; 204(11):1274-1285. PubMed ID: 34543591
[No Abstract] [Full Text] [Related]
8. Randomized, double-blind, controlled trial of human anti-LIGHT monoclonal antibody in COVID-19 acute respiratory distress syndrome.
Perlin DS; Neil GA; Anderson C; Zafir-Lavie I; Raines S; Ware CF; Wilkins HJ
J Clin Invest; 2022 Feb; 132(3):. PubMed ID: 34871182
[TBL] [Abstract][Full Text] [Related]
9. Corticosteroid therapy is associated with the delay of SARS-CoV-2 clearance in COVID-19 patients.
Huang R; Zhu C; Jian Wang ; Xue L; Li C; Yan X; Huang S; Zhang B; Zhu L; Xu T; Ming F; Zhao Y; Cheng J; Shao H; Zhao XA; Sang D; Zhao H; Guan X; Chen X; Chen Y; Wei J; Issa R; Liu L; Yan X; Wu C
Eur J Pharmacol; 2020 Dec; 889():173556. PubMed ID: 32941927
[TBL] [Abstract][Full Text] [Related]
10. High versus standard doses of corticosteroids in severe COVID-19: a retrospective cohort study.
Monreal E; Sainz de la Maza S; Natera-Villalba E; Beltrán-Corbellini Á; Rodríguez-Jorge F; Fernández-Velasco JI; Walo-Delgado P; Muriel A; Zamora J; Alonso-Canovas A; Fortún J; Manzano L; Montero-Errasquín B; Costa-Frossard L; Masjuan J; Villar LM;
Eur J Clin Microbiol Infect Dis; 2021 Apr; 40(4):761-769. PubMed ID: 33083917
[TBL] [Abstract][Full Text] [Related]
11. Early short course of neuromuscular blocking agents in patients with COVID-19 ARDS: a propensity score analysis.
Li Bassi G; Gibbons K; Suen JY; Dalton HJ; White N; Corley A; Shrapnel S; Hinton S; Forsyth S; Laffey JG; Fan E; Fanning JP; Panigada M; Bartlett R; Brodie D; Burrell A; Chiumello D; Elhazmi A; Esperatti M; Grasselli G; Hodgson C; Ichiba S; Luna C; Marwali E; Merson L; Murthy S; Nichol A; Ogino M; Pelosi P; Torres A; Ng PY; Fraser JF;
Crit Care; 2022 May; 26(1):141. PubMed ID: 35581612
[TBL] [Abstract][Full Text] [Related]
12. Role of the early short-course corticosteroids treatment in ARDS caused by COVID-19: A single-center, retrospective analysis.
Boglione L; Olivieri C; Rostagno R; Poletti F; Moglia R; Bianchi B; Esposito M; Biffi S; Borrè S
Adv Med Sci; 2021 Sep; 66(2):262-268. PubMed ID: 34022675
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 and corticosteroids: a narrative review.
El-Saber Batiha G; Al-Gareeb AI; Saad HM; Al-Kuraishy HM
Inflammopharmacology; 2022 Aug; 30(4):1189-1205. PubMed ID: 35562628
[TBL] [Abstract][Full Text] [Related]
14. No clinical benefit of high dose corticosteroid administration in patients with COVID-19: A preliminary report of a randomized clinical trial.
Jamaati H; Hashemian SM; Farzanegan B; Malekmohammad M; Tabarsi P; Marjani M; Moniri A; Abtahian Z; Haseli S; Mortaz E; Dastan A; Mohamadnia A; Vahedi A; Monjazebi F; Yassari F; Fadaeizadeh L; Saffaei A; Dastan F
Eur J Pharmacol; 2021 Apr; 897():173947. PubMed ID: 33607104
[TBL] [Abstract][Full Text] [Related]
15. Risk Factors for Severe Disease and Efficacy of Treatment in Patients Infected With COVID-19: A Systematic Review, Meta-Analysis, and Meta-Regression Analysis.
Zhang JJY; Lee KS; Ang LW; Leo YS; Young BE
Clin Infect Dis; 2020 Nov; 71(16):2199-2206. PubMed ID: 32407459
[TBL] [Abstract][Full Text] [Related]
16. A Review of the Evidence for Corticosteroids in COVID-19.
Johns M; George S; Taburyanskaya M; Poon YK
J Pharm Pract; 2022 Aug; 35(4):626-637. PubMed ID: 33719698
[TBL] [Abstract][Full Text] [Related]
17. Early steroids and ventilator-associated pneumonia in COVID-19-related ARDS.
Lamouche-Wilquin P; Souchard J; Pere M; Raymond M; Asfar P; Darreau C; Reizine F; Hourmant B; Colin G; Rieul G; Kergoat P; Frérou A; Lorber J; Auchabie J; La Combe B; Seguin P; Egreteau PY; Morin J; Fedun Y; Canet E; Lascarrou JB; Delbove A
Crit Care; 2022 Aug; 26(1):233. PubMed ID: 35918776
[TBL] [Abstract][Full Text] [Related]
18. Corticosteroids treatment in severe patients with COVID-19: a propensity score matching study.
Chen Q; Song Y; Wang L; Zhang Y; Han L; Liu J; Yang M; Ma J; Wang T
Expert Rev Respir Med; 2021 Apr; 15(4):543-552. PubMed ID: 33249945
[TBL] [Abstract][Full Text] [Related]
19. High-Dose Steroids for Nonresolving Acute Respiratory Distress Syndrome in Critically Ill COVID-19 Patients Treated With Dexamethasone: A Multicenter Cohort Study.
Lopinto J; Arrestier R; Peiffer B; Gaillet A; Voiriot G; Urbina T; Luyt CE; Bellaïche R; Pham T; Ait-Hamou Z; Roux D; Clere-Jehl R; Azoulay E; Gaudry S; Mayaux J; Mekontso Dessap A; Canoui-Poitrine F; de Prost N
Crit Care Med; 2023 Oct; 51(10):1306-1317. PubMed ID: 37199534
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 and Acute Respiratory Distress Syndrome. Impact of corticosteroid treatment and predictors of poor outcome.
Vidal-Cortés P; Del Río-Carbajo L; Nieto-Del Olmo J; Prol-Silva E; Tizón-Varela AI; Rodríguez-Vázquez A; Rodríguez-Rodríguez P; Díaz-López MD; Fernández-Ugidos P; Pérez-Veloso MA
Rev Esp Quimioter; 2021 Feb; 34(1):33-43. PubMed ID: 33317261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
